More can be read here as well. The issue goes back to a raid in 2006 of a US warehouse in New Jersey. If the pills were a problem, why were they allowed to continue to ship with allegations that factory test records were falsified. Well I guess this now gives us the answer while the investigation continues that if there are potential issues a halt should take place until all the facts are found since the involvement of the Department of Justice. BD
History: Congress and the Department of Justice now join the inquiry about the FDA actions investigating the alleged falsification of test records. This is where joint committees could also stand to shed some light here as both Australia and the UK are working with the FDA in reference to drug factories in China and India. As the Congressional investigation continues this certainly sets a real precedence to keep active inspections alive and going at all times as it stands to endanger the safety of lives with those taking the generic drugs.
In a major drug safety alert, the Food and Drug Administration announced today that the U.S. can refuse to import dozens of generic drugs taken by millions of Americans that are made by a major drug manufacturer in India.
The Food and Drug Administration announced Tuesday, Sept. 16, 2008, that the U.S. can refuse to import certain medications from Ranbaxy, a major manufacturer of generic drugs.
People taking any of 30 generic medications, such as the generics of Cipro, Alavert and Claritin, all made at two Ranbaxy plants in India, could be affected by today's alert.
But the FDA said that drug shortages are not expected in the United States, because, in all instances except for one, enough other suppliers can help meet demand for the medications.
0 comments :
Post a Comment